Personalized treatment for hepatocellular carcinoma in the era of targeted medicine and bioengineering

• Asıl Yazarlar: Hang Sun (Yazar), Huayu Yang (Yazar), Yilei Mao (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Frontiers Media S.A., 2023-05-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Hepatocellular carcinoma (HCC) is a major global health burden, causing approximately 8.3 million deaths each year, and it is the third leading cause of cancer-related death worldwide, with a relative 5-year survival rate of around 18%. Due to the advanced stage of diagnosis in most patients, system...